“Hydroxychloroquine” .. This is the name of the drug that US President Donald Trump announced his approval to treat the new Corona virus, and it is one of the drugs that was used to treat malaria, and the United States of America was not the first country to use this drug to treat corona.
France has previously announced its success in using this drug on a limited number of patients, as well as China, which is working on studying this drug with other drugs before America.
According to Reuters, US researchers, like scientists in other countries, have started studies to see if medicines for low-cost and widely available malaria can be used to help treat the disease caused by the new coronavirus.
Scientists at the University of Minnesota have begun trying hydroxychloroquine to treat malaria to 1,500 people this week to see if a drug can prevent or reduce the severity of the Corona virus. COVID-19.
Today, US President Trump has announced approval of this drug to treat the Corona virus.
China and France had announced the success of their experiments with the use of malaria in the treatment of corona, before the United States.
Earlier this week by the CEO Tesla Elon Musk , Who recovered from malaria in 2000 after taking the drug.
According to France 24, a well-known drug company has confirmed its readiness to provide millions of doses of Blaknell, a derivative of the anti-malarial hydroxychloroquine, which has shown “promising” results in treating patients with the Corona virus.
And that after a successful French study on experimenting with the drug on 24 people, the infection rate decreased among them to only 25%, as France continues its tests on the drug.
Blackknell is a drug composed of hydroxychloroquine molecules and has been used for decades in the treatment of malaria and autoimmune diseases such as lupus and arthritis. In addition to the direct anti-viral effect, hydroxychloroquine inhibits the production and release of proteins involved in the inflammatory complications of many viral diseases.
“We are trying to use science to see if we can do something,” said Dr. Jacob Tolar, dean of the University of Minnesota School of Medicine and vice president of clinical affairs.
Most people with the new coronavirus have only mild flu-like symptoms, but about 20% of them can suffer from a more serious disease that can lead to pneumonia that requires hospitalization.
“These treatments should only be used in hospitals by critical care professionals,” said Dr. Russell Bohr, a critical lung disease specialist at the University of California, Los Angeles.
Also this week, the University of Minnesota launched two trials of losartan – one to measure whether high blood pressure medication reduces the risk of organ failure for Corona patients. COVID-19 Those who have been hospitalized, the other is looking into whether the drug can reduce the need for hospitalization.
Losartan is an angiotensin 1 receptor blocker.AT1R), Which researchers say can play a role in blocking an enzyme that the virus uses to link to cells.
Pharmaceutical companies are also developing treatments for COVID-19 , Including antivirals that are given to hospital patients by intravenous infusion over several days.
– .
